Novartis India (BOM:500672) Long-Term Capital Lease Obligation : ₹51 Mil (As of Mar. 2024)

View and export this data going back to 1991. Start your Free Trial

What is Novartis India Long-Term Capital Lease Obligation?

Novartis India's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹51 Mil.

Novartis India's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (₹64 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹51 Mil).

Novartis India's annual Long-Term Capital Lease Obligation declined from Mar. 2022 (₹183 Mil) to Mar. 2023 (₹174 Mil) and declined from Mar. 2023 (₹174 Mil) to Mar. 2024 (₹51 Mil).

Novartis India Long-Term Capital Lease Obligation Historical Data

The historical data trend for Novartis India's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis India Long-Term Capital Lease Obligation Chart

Novartis India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

564.60

497.80

182.70

173.90

50.70

Novartis India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															173.90	-	64.30	-	50.70

Novartis India (BOM:500672) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Novartis India Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Novartis India's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis India (BOM:500672) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis India Ltd (BOM:500672) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051

Website

https://www.novartis.in

Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company single business segment namely Pharmaceuticals, Its Pharmaceutical business focuses on Bone and Pain, Calcium portfolio, Gynecology, and Neurosciences.

Novartis India (BOM:500672) Headlines

No Headlines